Optogenetic Activation of Direct-Pathway MSNs
Objective: To directly activate basal ganglia circuitry using optogenetic control of direct- and indirect-pathway medium spiny projection neurons (MSNs) and measure effects on motor behavior including freezing, bradykinesia, and locomotor initiation
This is a Optogenetic Activation of Direct-Pathway MSNs protocol using mouse as the model organism. The procedure involves 5 procedural steps, 2 equipment items, 1 materials. Extracted from a 2010 paper published in Nature.
Model and subjects
mouse • D1-Cre and D2-Cre BAC transgenic mice • Not specified • Not specified • Not specified • Not specified
Study window
Estimated timing pending
Core workflow
Viral vector preparation and injection • Stereotaxic injection into striatum • Optogenetic activation of indirect-pathway MSNs
Primary readouts
- Freezing behavior
- Bradykinesia (slow movement)
- Locomotor initiation
- Locomotion
Key equipment and reagents
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
- Verify the animal model, intervention setup, and collection timepoints against the source paper.
- Check that every direct vendor link matches the exact specification your lab plans to run.
Use the page like this
- Work through the protocol steps in order and use the inline vendor chips only when you need to source or verify an item.
- Jump to Experimental Context for readouts, data shape, and analysis flow before planning downstream analysis.
Protocol Steps
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Viral vector preparation and injection
Prepare Cre-dependent viral expression vectors containing channelrhodopsin-2 for injection into striatum
Note: Vectors designed for Cre-dependent expression in D1-Cre and D2-Cre transgenic mice
View evidence from paper
“Cre-dependent viral expression of channelrhodopsin-2 in the striatum of D1-Cre and D2-Cre BAC transgenic mice”
Stereotaxic injection into striatum
Inject viral vectors containing channelrhodopsin-2 into the striatum of transgenic mice
Note: Bilateral injection to target both direct and indirect pathway MSNs
View evidence from paper
“Cre-dependent viral expression of channelrhodopsin-2 in the striatum of D1-Cre and D2-Cre BAC transgenic mice”
Optogenetic activation of indirect-pathway MSNs
Bilaterally excite indirect-pathway MSNs using optogenetic stimulation and observe resulting motor behavior
Note: Activation elicits parkinsonian state with increased freezing, bradykinesia, and decreased locomotor initiations
View evidence from paper
“Bilateral excitation of indirect-pathway MSNs elicited a parkinsonian state, distinguished by increased freezing, bradykinesia, and decreased locomotor initiations”
Optogenetic activation of direct-pathway MSNs
Activate direct-pathway MSNs using optogenetic stimulation and measure effects on motor behavior
Note: Activation reduces freezing and increases locomotion
View evidence from paper
“activation of direct-pathway MSNs reduced freezing and increased locomotion”
Testing in Parkinson's disease model
Apply direct pathway activation in a mouse model of Parkinson's disease to assess therapeutic potential
Note: Direct pathway activation completely rescued deficits in freezing, bradykinesia, and locomotor initiation
View evidence from paper
“In a mouse model of Parkinson's disease, direct pathway activation completely rescued deficits in freezing, bradykinesia, and locomotor initiation”